Healthcare provider profile · identity verified

Hilary Clinger, NP

Family Practice · JAMESTOWN, NY · NPI 1629610654

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	760	54
Amlodipine Besylate	Amlodipine Besylate	396	37
Lisinopril	Lisinopril	348	34
Gabapentin	Gabapentin	239	20
Pantoprazole Sodium	Pantoprazole Sodium	232	20
Jardiance	Empagliflozin	221	13
Sertraline Hcl	Sertraline Hcl	217	17
Metoprolol Succinate	Metoprolol Succinate	216	15
Omeprazole	Omeprazole	213	22
Tamsulosin Hcl	Tamsulosin Hcl	209	14
Eliquis	Apixaban	184	15
Losartan Potassium	Losartan Potassium	182	17
Alendronate Sodium	Alendronate Sodium	177	12
Hydrochlorothiazide	Hydrochlorothiazide	176	17
Trazodone Hcl	Trazodone Hcl	176	13
Levothyroxine Sodium	Levothyroxine Sodium	158	17
Duloxetine Hcl	Duloxetine Hcl	144	13
Bumetanide	Bumetanide	130	19
Metformin Er Osmotic	Metformin Hcl	120	suppressed
Metformin Hcl Er	Metformin Hcl	118	suppressed
Furosemide	Furosemide	108	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	100	suppressed
Famotidine	Famotidine	97	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	94	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	91	suppressed
Levetiracetam	Levetiracetam	89	suppressed
Meloxicam	Meloxicam	88	11
Carvedilol	Carvedilol	86	suppressed
Oxycodone Hcl	Oxycodone Hcl	86	21
Simvastatin	Simvastatin	82	suppressed
Mirtazapine	Mirtazapine	80	suppressed
Potassium Chloride	Potassium Chloride	76	15
Metoprolol Tartrate	Metoprolol Tartrate	74	11
Aripiprazole	Aripiprazole	70	suppressed
Buspirone Hcl	Buspirone Hcl	65	suppressed
Carvedilol Er	Carvedilol Phosphate	65	suppressed
Clonazepam	Clonazepam	64	suppressed
Xarelto	Rivaroxaban	64	suppressed
Pravastatin Sodium	Pravastatin Sodium	62	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	59	suppressed
Spironolactone	Spironolactone	59	suppressed
Warfarin Sodium	Warfarin Sodium	57	suppressed
Risperidone	Risperidone	54	suppressed
Glipizide Er	Glipizide	52	suppressed
Metformin Hcl	Metformin Hcl	52	suppressed
Risedronate Sodium	Risedronate Sodium	52	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	suppressed
Celecoxib	Celecoxib	50	suppressed
Mirabegron Er	Mirabegron	50	suppressed
Buprenorphine	Buprenorphine	48	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	45	suppressed
Folic Acid	Folic Acid	44	suppressed
Baclofen	Baclofen	43	suppressed
Tramadol Hcl	Tramadol Hcl	43	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	38	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Prednisone	Prednisone	34	11
Vitamin D2	Ergocalciferol (Vitamin D2)	34	suppressed
Colchicine	Colchicine	33	suppressed
Glimepiride	Glimepiride	33	suppressed
Methenamine Hippurate	Methenamine Hippurate	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Nystatin	Nystatin	30	16
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	30	suppressed
Leflunomide	Leflunomide	29	suppressed
Methotrexate	Methotrexate Sodium	29	suppressed
Primidone	Primidone	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Glipizide	Glipizide	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Phenytek	Phenytoin Sodium Extended	27	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	27	suppressed
Glycopyrrolate	Glycopyrrolate	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Temazepam	Temazepam	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	13
Montelukast Sodium	Montelukast Sodium	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Ozempic	Semaglutide	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Ibuprofen	Ibuprofen	20	13
Valsartan	Valsartan	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Mounjaro	Tirzepatide	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Finasteride	Finasteride	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Etodolac	Etodolac	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error